These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 6211399)

  • 21. Reversal of thromboxane A2/prostaglandin H2 and ADP-induced calcium release in intact platelets.
    Brace LD; Venton DL; Le Breton GC
    Am J Physiol; 1985 Jul; 249(1 Pt 2):H8-13. PubMed ID: 2409821
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of platelet aggregation and thromboxane synthesis after intake of small amount of icosapentaenoic acid.
    Driss F; Vericel E; Lagarde M; Dechavanne M; Darcet P
    Thromb Res; 1984 Dec; 36(5):389-96. PubMed ID: 6098051
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Thrombocyte interaction with a collagen substrate: the role of thrombocyte-synthesized prostaglandin endoperoxides and thromboxane A2].
    Mazurov AB; Leĭtin VL; Repin VS
    Biull Eksp Biol Med; 1984 Nov; 98(11):563-6. PubMed ID: 6439262
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phenothiazine compounds enhance phentolamine effects on platelet aggregation and thromboxane B2 production.
    Anfossi G; Trovati M; Mularoni E; Massucco P; Cavalot F; Mattiello L; Emanuelli G
    Arch Int Pharmacodyn Ther; 1990; 307():142-61. PubMed ID: 1982777
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aggregation of killer whale platelets.
    Patterson WR; Dalton LM; McGlasson DL; Cissik JH
    Thromb Res; 1993 May; 70(3):225-31. PubMed ID: 8327987
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of platelet thromboxane synthesis by 7-(1-imidazolyl) heptanoic acid: dissociation from inhibition of aggregation.
    Grimm LJ; Knapp DR; Senator D; Halushka PV
    Thromb Res; 1981 Nov; 24(4):307-17. PubMed ID: 6801806
    [No Abstract]   [Full Text] [Related]  

  • 27. Modification of platelet aggregation and thromboxane synthesis by intravascular contrast media.
    Paajanen H; Kormano M; Uotila P
    Invest Radiol; 1984; 19(4):333-7. PubMed ID: 6434489
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of platelet aggregation and thromboxane B2 production during aspirin treatment: dependence on the dose of the aggregating agent.
    De Caterina R; Giannessi D; Gazzetti P; Bernini W
    Thromb Res; 1985 Jan; 37(2):337-42. PubMed ID: 3975876
    [No Abstract]   [Full Text] [Related]  

  • 29. The interrelationship between thromboxane biosynthesis, aggregation and 5-hydroxytryptamine secretion in human platelets in vitro.
    Best LC; Holland TK; Jones PB; Russell RG
    Thromb Haemost; 1980 Feb; 43(1):38-40. PubMed ID: 6773171
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Megakaryocyte thromboxane production induced by platelet stimuli during in vitro culture.
    Walenga RW; Miller JL; Stuart MJ
    Exp Hematol; 1985 Feb; 13(2):87-91. PubMed ID: 3918879
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of pyridoxal 5'-phosphate (PALP) on human platelet aggregation, dense granule release and thromboxane B2 generation--role of Schiff base formation.
    Krishnamurthi S; Westwick J; Kakkar VV
    Thromb Haemost; 1982 Oct; 48(2):136-41. PubMed ID: 6891107
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Platelet rich plasma transforms exogenous prostaglandin endoperoxide H2 into thromboxane A2.
    Fitzpatrick FA; Gorman RR
    Prostaglandins; 1977 Nov; 14(5):881-9. PubMed ID: 594390
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of sympathomimetic amines with collagen, calcium ionophor and adenosine diphosphate in their effects on thromboxane formation of human platelet rich plasma.
    Ditter H; Matthias FR; Lasch HG
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(6):761-8. PubMed ID: 6083951
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adrenaline potentiates type 2B von Willebrand factor-induced activation of human platelets by enhancing both the formation and action of thromboxanes.
    Francesconi M; Scapin M; Casonato A; Girolami A; Deana R
    Thromb Res; 2000 Nov; 100(4):293-303. PubMed ID: 11113273
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bleeding disorder associated with albumin-dependent partial deficiency in platelet thromboxane production. Effect of albumin on arachidonate metabolism in platelets.
    Rao AK; Koike K; Day HJ; Smith JB; Holmsen H
    Am J Clin Pathol; 1985 Jun; 83(6):687-96. PubMed ID: 3923822
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of cholesterol on production of thromboxane b2 by platelets in vitro.
    Stuart MJ; Gerrard JM; White JG
    N Engl J Med; 1980 Jan; 302(1):6-10. PubMed ID: 7350406
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Theophylline inhibits platelet aggregation, prostaglandin and thromboxane production by a mechanism which is independent of cyclic AMP.
    Burns GB; Dodge JA
    Agents Actions; 1984 Jan; 14(1):102-8. PubMed ID: 6322546
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhanced platelet release reaction, shortened platelet survival time and increased platelet aggregation and plasma thromboxane B2 in chronic obstructive arterial disease.
    Zahavi J; Zahavi M
    Thromb Haemost; 1985 Feb; 53(1):105-9. PubMed ID: 3158092
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel eicosanoids generated by cytochrome P450: effects on platelet aggregation and protein phosphorylation.
    Malcolm K; Falck JR; Fitzpatrick FA
    Adv Prostaglandin Thromboxane Leukot Res; 1990; 20():87-94. PubMed ID: 2144702
    [No Abstract]   [Full Text] [Related]  

  • 40. Thromboxane B2 production and lipid peroxidation in human blood platelets.
    Best LC; Jones PB; McGuire MB; Russell RG
    Adv Prostaglandin Thromboxane Res; 1980; 6():297-9. PubMed ID: 7386271
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.